EUVIMEDEUVIMED entdecken
Open Access

GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer

Alexandre B Le Roux, Edward K Fung, Sang Gyu Lee, Sebastien Monette, Hong Xu, Hong-Fen Guo, Guangbin Yang, Ouathek Ouerfelli, Achim Jungbluth, Heiko Schöder, Steven M Larson, Nai-Kong V Cheung und 2 weitere

Theranostics · 2025

DOI: 10.7150/thno.107209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Alexandre B Le Roux und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Radioimmunotherapy, Colorectal Neoplasms, Lutetium, Radioisotopes. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadioimmunotherapyColorectal NeoplasmsLutetiumRadioisotopesLiver NeoplasmsRadiopharmaceuticalsAnimalsMiceHumansHeterocyclic Compounds, 1-RingXenograft Model Antitumor AssaysCell Line, TumorTissue DistributionAntibodies, BispecificMice, NudeFemaleMembrane Glycoproteins

Stichwörter der Autor:innen

Lu-177colorectal cancer hepatic metastasismultivalent radiohaptenpretargeted radioimmunotherapytheranostics

Substanzen

LutetiumRadioisotopesLutetium-177Heterocyclic Compounds, 1-Ring1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidGPA33 protein, humanRadiopharmaceuticalsAntibodies, BispecificMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Radiology, Weill Cornell Medicine, New York, NY.
  • Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and Rockefeller University, New York, NY.
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Förderung

  • NCI NIH HHS

Zitieren

APA

Le Roux, A. B., Fung, E. K., Lee, S. G., Monette, S., Xu, H., Guo, H. F., Yang, G., Ouerfelli, O., Jungbluth, A., Schöder, H., Larson, S. M., Cheung, N. V., Cheal, S. M., & Veach, D. R. (2025). GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer. Theranostics. https://doi.org/10.7150/thno.107209

Vancouver

Le Roux AB, Fung EK, Lee SG, Monette S, Xu H, Guo HF, et al. GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer. Theranostics. 2025. doi:10.7150/thno.107209

BibTeX
@article{LeRoux2025,
  author = {Le Roux, Alexandre B and Fung, Edward K and Lee, Sang Gyu and Monette, Sebastien and Xu, Hong and Guo, Hong-Fen and Yang, Guangbin and Ouerfelli, Ouathek and Jungbluth, Achim and Schöder, Heiko and Larson, Steven M and Cheung, Nai-Kong V and Cheal, Sarah M and Veach, Darren R},
  title = {GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.107209}
}
Kostenlos starten →